Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
This study is currently recruiting participants.
Verified October 2017 by George E. Peoples, Cancer Insight, LLC
George E. Peoples
First Posted: April 4, 2012
Last Update Posted: October 31, 2017
Galena Biopharma, Inc.
Information provided by (Responsible Party):
George E. Peoples, Cancer Insight, LLC
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||June 2020|
|Estimated Primary Completion Date:||June 2019 (Final data collection date for primary outcome measure)|